Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04065555
Title Intratumoral Microdosing of TAK-981 in Head and Neck Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Presage Biosciences
Indications

head and neck cancer

Therapies

Avelumab + TAK-981

Cetuximab

Cetuximab + TAK-981

TAK-981

Avelumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.